Popular Articles

Innovative Medicines Initiative: 246 Million Euros To Support Public-private Research Cooperation For A Fast Development Of Better Medicines
Today, 15 new research projects aimed at bringing innovative medicines more quickly to the market have been selected to receive 246 million euros from the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The projects will foster understanding of health issues such as diabetes, pain, severe asthma and psychiatric disorders while increasing drug safety. They will also help improve the training of researchers and clinicians involved in medicines development. The projects were chosen following the first call for proposals launched within the Innovative Medicines Initiative (IMI), a public-private partnership - so called Joint Technology Initiative- between the European Commission and the pharmaceutical industry. With this selection, IMI has reached a key milestone. This initiative marks the first time that pharmaceutical competitors are pooling their res, together with research organisations, patient groups and other stakeholders in large consortia, in order to develop generic, pre-competitive knowledge. The Commission"s contribution of €110 million is backed up with €136 million provided in-kind from the pharmaceutical industry. The successful projects will now enter into the final negotiation phase.
generic viagra online
National Medical Societies Offer Tips To Prevent Injuries; Children Often Victims
- Using a lawn mower can be as routine as bike riding or barbeques during spring and summer months. But often, people find themselves in terrifying situations with these seemingly safe household machines. In fact, 200,000 people - 16,000 of them children - are injured in lawn mower-related accidents each year, the U.S. Consumer Product Safety Commission reports. However, lawn mowers don"t "attack" on their own. Most injuries - such as severed fingers and toes, limb amputations, broken bones, burns and eye injuries - are caused by careless use and can be prevented by following a few simple safety tips.
News of the day
PLC Medical Systems Announces Publication Of Care Study Update
PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, announced that a follow-up study of the landmark Cardiac Angiography in Renally Impaired Patients (CARE) Study determined that Contrast-Induced Nephropathy (CIN) is associated with long-term adverse events, ranging from pulmonary edema to death, and that patients with CIN were twice as likely as those who did not develop CIN to experience adverse events.
Mental Health

DrugScope: NTA Naloxone Pilot Scheme Can Help Reduce Drug-related Deaths, UK

DrugScope has today welcomed the National Treatment Agency"s announcement of a pilot scheme that will see families and carers of opiate users trained in drug overdose management and the administration of naloxone, a drug which reverses the effects of a drug overdose [1]. Naloxone is an opioid antagonist which blocks the effects of opiates, such as heroin or methadone. When administered to somebody who has overdosed on opiates, the overdose is reversed for long enough for medical assistance to arrive. Naloxone can be administered by injection straight into muscle tissue (intra-muscular), although the drug can also be injected intravenously. Evidence suggests that naloxone does not cause dependency and the drug would have to be used in substantial quantities to have harmful effects. Under the pilot scheme announced today, families and carers in sixteen cities in England will be provided with training and information on basic life support techniques, overdose awareness (i.e. how to recognise the symptoms and risk factors), and how to administer naloxone safely. The scheme will also encourage drug users to consider the risks associated with their drug use and available drug treatment options. Responding to today"s announcement, DrugScope Chief Executive Martin Barnes said: "More needs to be done to reduce drug-related deaths in the UK, and this pilot scheme is a welcome move. Naloxone can save lives and is routinely used by paramedics to reverse opiate overdoses. Equipping carers and families with naloxone, and training in how to administer it safely, could make a vital difference in keeping someone alive long enough for an ambulance to arrive. "Today"s family-based pilot is a positive development which improves the coverage of naloxone provision and helps involve families and carers to support a loved one. The majority of drug overdoses happen when the user is in the company of others and in some cases, an overdose may take place while the user is at their family home. However, overdoses often happen while the user is with other drug users and DrugScope would welcome an extension of the pilot to ensure that naloxone and overdose prevention training is provided to drug users and their peers, as well as families and carers." [1] About the National Treatment Agency pilots The NTA was setup by the Government in 2001 to improve the availability, capacity and effectiveness of treatment for drug misuse in England. For more information visit: http://www.nta.nhs.uk The 16 sites who will be running the pilots are: Birmingham and Solihull Mental Health Foundation Trust Bolton Drug and Alcohol Strategy and Commissioning Team & Bolton Drug Service (part of Greater Manchester West NHS Foundation Trust) Bradford and Airedale Substance Misuse Service in partnership with The Bridge Project London Central and North West London (CNWL): NHS Foundation Trust Carers Service & Max Glatt Inpatient Detoxification Unit - Ealing) DASH, Hereford Drugline Lancashire Durham (Tees, Esk and Wear Valley NHS Trust) & Lambeth CDAT- Lorraine Hewitt House (SLAM) Hampshire Partnership NHS Trust Substance Misuse Services (Southampton City DAAT) Harbour drug and alcohol service, Plymouth DAAT KCA (UK), Kent National Addiction Centre (South London and Maudsley NHS Foundation Trust) Newcastle PROPs Relatives of Drug Abusers (RODA) and Primary Care Addiction Service Sheffield (Sheffield PCT) Shropshire Service Users Network (SUN) Wigan and Leigh Substance Misuse Services (part of Greater Manchester West NHS Foundation Trust) KCA (UK) and CRI, Kent Drug and Alcohol Team (DAAT) National Treatment Agency


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):